Skip to content

DermoSight Software DXH-SW-100

by Deepx Health, LLC

DermoSight Software DXH-SW-100 is a dermatoscope (FDA Class II; FDA product code PSN, Light Based Imaging) made by Deepx Health, LLC, listed in FDA GUDID since 19 Jun 2025 (UDI-DI 00860013961411), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860013961411 UDI-DI Date19 Jun 2025ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Web-based software for dermatoscope image capture and analysis
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
DermoSight Software
Generic name
Dermatoscope, optical
Model / Ref / Catalog
DXH-SW-100
Primary DI / UDI-DI
00860013961411
FDA product code
PSN
GMDN term
Dermatoscope, optical
Device class
Class II
Regulation number
878.4580
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code PSN (Light Based Imaging).

Other devices from Deepx Health, LLC

Properties

  • Prescription use
  • Combination product
  • Manufacturing date
Other properties (12, all answered No)